We have developed a live varicella vaccine which has been passaged in guinea pig embryonic cells 12 times (14, 15). This vaccine has been widely used, tnainly for immunocompromised children, conferring high immunity against varicella without adverse clinical reaction (4, 13) . The immunopathological study of varicella-zoster virus (VZV) has long been hampered by the lack of a suitable experimental system using small animals, although monkeys have been used (5, 10, 11) . In the investigation of biological markers of the vaccine virus, we found that the vaccine virus induced neutralizing or complement-fixing antibody response in guinea pigs when administered by subcutaneous inoculation, whereas little or no such response was observed with other wild-type strains (13, 18). Recently Myers et al. (8) reported that weanling guinea pigs inoculated intranasally or subcutaneously with VZV grown in fetal guinea pig tissue culture shed virus from the nasopharynx and seroconverted to VZV. Animal-to-animal transmission of VZV was also observed by them. In the present study we confirmed the observation of Myers et al., extending the VZV strains used for inoculation and the routes of inoculation, i.e., via a corneal route. Furthermore, the time course of humoral and cellular immune responses in guinea pigs inoculated with VZV (Oka vaccine strain) was investigated by the fluorescent antibody to membrane antigen (FAMA) test and by the varicella skin test, which represents delayed-type hypersensitivity (DTH). In addition, replication of VZV of various strains in cultured guinea pig cells was investigated in connection with the above in vivo experiments.
MATERIALS AND METHODS Cells. Human embryonic fibroblast (HuEF) or lung (HEL) cells were grown in Roux bottles, using a mixture of an equal amount of Eagle minimum essential medium and medium 199 supplemented with 10 or 3% calf serum for growth or maintenance medium, respectively. All media contained 100 U of penicillin and 100 p.g of streptomycin per ml. Cells were subcultured at 6-to 7-day intervals, and cultures from the 5th to the 15th passage were used for the experiments. Cells were not contaminated with mycoplasma. Primary cultures of guinea pig embryonic kidney (GPEK), lung (GPEL), skin (GPES), and fibroblast (GPEF) cells were prepared from White Hartley guinea pig embryos, using the same media as above. The second-passaged cells were used for the virus infection.
Virus. Oka, Kawaguchi (14) , and Inoue strains were isolated from vesicles of varicella patients and passaged 5, 10, and 5 times, respectively, in HEL cells. Oka vaccine strain was passaged 11 times in HEL cells and 12 times in GPEF cells and then propagated in human diploid cells (14, 15). Inoue strain, passaged nine times in GPEF cells after five passages in HEL cells, was also used. For the passages of virus, infected cells were trypsinized, suspended in maintenance medium, and inoculated to fresh cell sheet at a ratio of approximately 1 infected cell to 5 uninfected cells. Cell-free virus was obtained by the sonication method described previously (2) .
UV irradiation. Two milliliters of virus preparation was irradiated in 60-mm plastic plates with a UV germicidal lamp at a distance producing a radioactive dose of 50 erg mm-2 s-' for 10 min, resulting in a complete loss of infectivity. Animals and VZV inoculation of animals. Male White Hartley guinea pigs weighing about 200 g were used for VZV infection. Cell-free virus prepared from infected HEL cells or infected GPEF cells were administered to animals by subcutaneous, corneal, or nasal routes. GPEF cells infected with the Oka vaccine strain were harvested when more than 80%o of the cell sheet showed cytopathic effect. The numbers of infected cells were calculated on HuEF cells by an infectious center assay (17) just before the animals were inoculated. In corneal inoculation, the animals were anesthetized with ether, and the cornea of each eye was scarified with a sterile 25-gauge needle. Then 0.1 ml of virus suspension was dropped onto the surface of the eye. In nasal inoculation, the animals were likewise anesthetized, and 0.1 ml of virus suspension was dropped into each nostril. In subcutaneous inoculation, 0. (1, 6) , except for using guinea pig embryonic cells instead of human diploid cells.
Oka vaccine strain was used for infection. After a monolayer of GPEF cells had formed, the medium was decanted, and the cells were inoculated with infected GPEF cells. When extensive cytopathic effect appeared after incubation at 37°C, the cell sheet was washed three times with PBS. Then the cells were collected with a rubber policeman, pelleted by centrifugation at 3,000 rpm, and suspended in PBS. The cell suspension was sonicated (Tomy Ultrasonic Disrupter, model UR-200W output 11, for 30 s), followed by centrifugation at 3,000 rpm for 10 min at 4°C. The supernatant was harvested and, after heating at 56°C for 30 min, stored at -80°C until testing. The test antigen had the antigen titer of 1:2 to 1:4 in the complement-fixing test, using human zoster convalescent serum. Control antigen, having a protein content comparable to that of the testing antigen, was prepared from uninfected GPEF cells in the same way.
The backs of the animals were shaved with an electric clipper, and intradermal inoculation of 0.1 ml of testing antigen and control antigen was done with 25-gauge needles. Inoculation sites were examined at 48 h after injection. Since repeated skin tests might result in an enhancement of the immunological reaction of guinea pigs, animals were challenged only once.
Inoculation of VZV to guinea pig cell cultures. Monolayers of GPEK, GPEL, and GPES cells in 60-mm plastic plates were inoculated with cell-free virus. After 1 h of adsorption at 37°C, cultures were washed with PBS three times, flooded with the maintenance medium, and kept at 37°C. Cells were trypsinized at 4, 24, 48, 72, %, and 120 h after infection and suspended in 2 ml of maintenance medium per plate, and 0. Table 2 ). The range of their antibody titers was between 1:8 and 1:16. Three of four guinea pigs showed antibody responses when they were inoculated by the corneal route with infected cells, and four of five guinea pigs showed antibody responses when inoculated by the same route with cell-free virus. Two of three guinea pigs showed antibody response when they were inoculated with infected cells by the nasal route, and four of five guinea pigs showed antibody responses when inoculated by the same route with cell-free virus. The level of antibody titer induced by the nasal route was lower than that induced by the subcutaneous route. Clinical symptoms, such as exanthema, were not observed in any guinea pig by any method of inoculation.
Antibody responses of guinea pigs inoculated with live or UV-inactivated VZV of Oka vaccine strain by corneal route. Ten guinea pigs were inoculated by the corneal route with cell-free virus of Oka vaccine strain having the titer of 6.0 x 102 PFU/dose or UV-inactivated virus having the same titer before irradiation, with five animals for each group. Antibody response occurred in four of five guinea pigs inoculated with live virus, but no guinea pig showed antibody response with UV-irradiated virus ( (Fig. 1) . On day 4, two offour guinea pigs responded with skin reaction, and all animals showed the skin reaction after 8 days. On the other hand, antibody responses were not detected until day 6, but all animals showed antibody increases on day 10 (Fig. 2) . When the immunological examination was done 4 months after infection, both humoral and cellular immunities were found to persist.
Adsorption and growth of VZV of various strains in cultured guinea pig embryonic cells. GPEL, GPES, and GPEK cells were inoculated with cell-free virus of Oka (vaccine), Oka (HEL, 5th passage), Kawaguchi (HEL, 10th passage), and Inoue (HEL, 5th passage) strains to compare the adsorption and growth of viruses in these cells. The conventional method to examine adsorption and growth of virus seemed unsuitable for the purpose of the present study,because the infectivity of VZV is not stable under usual environmental conditions, and the yields of cell-free infectious virus from guinea pig cultures were not large enough to permit depiction of the precise growth curve of the viruses. Therefore, infectious center assay was performed at 4 h after infection (early stage of infection) and at later hours (advanced stage of infection) to assess the adsorption and growth of viruses. GPEL and GPES cells were far more susceptible to VZV, 30 to 50 times higher than GPEK cells, when Oka vaccine strain was used for infection (Table 6 ). Oka But iously that a varicella vac-the antibody titers induced in the untreated in) induced neutralizing or cagemates were considerably lower than those ntibody in guinea pigs by subcutaneously injected. This might be due to ation, whereas other wild-the rather poor susceptibility of respiratory tract 3, 18). This was thought to cells of guinea pigs, as observed in the preceding ice of passage history of the nasal inoculation experiments.
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